This track focuses on the latest advancements in drug formulation technologies and methodologies. Participants will explore novel approaches to enhance drug delivery and efficacy.

This session delves into the role of pharmacogenomics in tailoring drug therapies to individual genetic profiles. Discussions will highlight the implications for patient outcomes and treatment optimization.

This track examines the potential of natural products as sources of new therapeutic agents. Researchers will present findings on bioactive compounds derived from plants, fungi, and marine organisms.

This session addresses the regulatory landscape affecting pharmacy practice and drug development. Experts will discuss compliance, safety assessments, and the impact of regulations on innovation.

This track explores the integration of alternative therapies within conventional healthcare practices. Presentations will focus on evidence-based approaches and patient-centered care models.

This session highlights the role of informatics and digital tools in enhancing pharmacy practice. Topics will include electronic health records, telepharmacy, and data analytics in medication management.

This track investigates the challenges posed by antimicrobial resistance in clinical settings. Discussions will focus on innovative strategies for effective pharmacotherapy and stewardship.

This session covers the methodologies and ethical considerations in conducting clinical trials for new pharmaceuticals. Participants will learn about trial design, patient recruitment, and data analysis.

This track addresses the evolving landscape of pharmacy education and its impact on workforce readiness. Topics will include curriculum development, competency-based training, and lifelong learning.

This session focuses on strategies to enhance patient safety in medication management. Key discussions will revolve around error prevention, medication reconciliation, and patient education.

This track explores cutting-edge drug delivery technologies and their implications for therapeutic efficacy. Participants will discuss advancements in nanotechnology, targeted delivery, and sustained release systems.